A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors

Clinical trial NCT03997968 · COMPLETED

Trial details

NCT number: NCT03997968
Sponsor: Cyteir Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignancy Non-hodgkin Lymphoma Multiple Myeloma Breast Cancer Ovarian Cancer Soft Tissue Sarcoma Head and Neck Cancer DLBCL Mantle Cell Lymphoma Follicular Lymphoma Pancreatic Cancer CLL

Start date: 2019-10-09
Primary completion: 2024-11-30
Enrollment: 169

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.